Because of the emergence of a whole range of new diseases that affect humans, as well as the increasing problems of resistance to certain existing drug families. The need to design effective drugs is very important. The development of drugs today is growing in the sense of not only finding new drugs but also reducing the time and the cost of this procedure. The work done during this study is the in silico design of heterocyclic molecules potentially interesting drug precursors in the treatment of certain bacterial infections or in chemotherapy. The employed strategy involves the use of computational methods based on different methods of bioinformatics and biostatistics (QSAR-2D, QSAR-3D, Molecular Docking and the Druglike or ADME-Toxic...) to better rationalize the design of new drug with specific structures, better activities and good affinities against better targets.
Les informations fournies dans la section « Synopsis » peuvent faire référence à une autre édition de ce titre.
Vendeur : BuchWeltWeit Ludwig Meier e.K., Bergisch Gladbach, Allemagne
Taschenbuch. Etat : Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -Because of the emergence of a whole range of new diseases that affect humans, as well as the increasing problems of resistance to certain existing drug families. The need to design effective drugs is very important. The development of drugs today is growing in the sense of not only finding new drugs but also reducing the time and the cost of this procedure. The work done during this study is the in silico design of heterocyclic molecules potentially interesting drug precursors in the treatment of certain bacterial infections or in chemotherapy. The employed strategy involves the use of computational methods based on different methods of bioinformatics and biostatistics (QSAR-2D, QSAR-3D, Molecular Docking and the Druglike or ADME-Toxic.) to better rationalize the design of new drug with specific structures, better activities and good affinities against better targets. 132 pp. Englisch. N° de réf. du vendeur 9786200118004
Quantité disponible : 2 disponible(s)
Vendeur : moluna, Greven, Allemagne
Etat : New. Dieser Artikel ist ein Print on Demand Artikel und wird nach Ihrer Bestellung fuer Sie gedruckt. Autor/Autorin: Zaki HananeHanane Zaki, who holds a Master s degree in biotechnology and enhancement of aromatic and medicinal plants from the Faculty of Science of Meknes, is a PhD student at Biology, Environment and Health Laboratory in the Facult. N° de réf. du vendeur 385885126
Quantité disponible : Plus de 20 disponibles
Vendeur : Revaluation Books, Exeter, Royaume-Uni
Paperback. Etat : Brand New. 132 pages. 8.66x5.91x0.30 inches. In Stock. N° de réf. du vendeur zk6200118000
Quantité disponible : 1 disponible(s)
Vendeur : buchversandmimpf2000, Emtmannsberg, BAYE, Allemagne
Taschenbuch. Etat : Neu. This item is printed on demand - Print on Demand Titel. Neuware -Because of the emergence of a whole range of new diseases that affect humans, as well as the increasing problems of resistance to certain existing drug families. The need to design effective drugs is very important. The development of drugs today is growing in the sense of not only finding new drugs but also reducing the time and the cost of this procedure. The work done during this study is the in silico design of heterocyclic molecules potentially interesting drug precursors in the treatment of certain bacterial infections or in chemotherapy. The employed strategy involves the use of computational methods based on different methods of bioinformatics and biostatistics (QSAR-2D, QSAR-3D, Molecular Docking and the Druglike or ADME-Toxic.) to better rationalize the design of new drug with specific structures, better activities and good affinities against better targets.VDM Verlag, Dudweiler Landstraße 99, 66123 Saarbrücken 132 pp. Englisch. N° de réf. du vendeur 9786200118004
Quantité disponible : 1 disponible(s)
Vendeur : preigu, Osnabrück, Allemagne
Taschenbuch. Etat : Neu. Computer Design of New Heterocyclic Molecules as Drug Precursors | New candidate drugs in the treatment of cancer and microbial infections using bioinformatics and biostatistics tools | Hanane Zaki (u. a.) | Taschenbuch | 132 S. | Englisch | 2019 | LAP LAMBERT Academic Publishing | EAN 9786200118004 | Verantwortliche Person für die EU: preigu GmbH & Co. KG, Lengericher Landstr. 19, 49078 Osnabrück, mail[at]preigu[dot]de | Anbieter: preigu. N° de réf. du vendeur 116961412
Quantité disponible : 5 disponible(s)
Vendeur : AHA-BUCH GmbH, Einbeck, Allemagne
Taschenbuch. Etat : Neu. nach der Bestellung gedruckt Neuware - Printed after ordering - Because of the emergence of a whole range of new diseases that affect humans, as well as the increasing problems of resistance to certain existing drug families. The need to design effective drugs is very important. The development of drugs today is growing in the sense of not only finding new drugs but also reducing the time and the cost of this procedure. The work done during this study is the in silico design of heterocyclic molecules potentially interesting drug precursors in the treatment of certain bacterial infections or in chemotherapy. The employed strategy involves the use of computational methods based on different methods of bioinformatics and biostatistics (QSAR-2D, QSAR-3D, Molecular Docking and the Druglike or ADME-Toxic.) to better rationalize the design of new drug with specific structures, better activities and good affinities against better targets. N° de réf. du vendeur 9786200118004
Quantité disponible : 1 disponible(s)